Caricamento...
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data
Dexamethasone, a synthetic glucocorticoid, has previously shown mortality benefit in severe coronavirus disease 2019 (COVID-19) in a randomized controlled trial. As the illness is considered to reflect a hyperinflammatory state, this therapeutic effectiveness is presumably ascribed to broad anti-inf...
Salvato in:
| Pubblicato in: | Gene |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier B.V.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054526/ https://ncbi.nlm.nih.gov/pubmed/33887367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gene.2021.145665 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|